Related Experiment Video
Updated: May 17, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Detecting and managing hereditary colorectal cancer syndromes in your practice
Brandie Heald1, James Church, Thomas Plesec
1Genomic Medicine Institute, Taussig Cancer Institute, The Sanford R. Weiss Center for Inherited Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH 44195, USA. leachb@ccf.org
Abstract:
Hereditary syndromes account for 5% to 10% of cases of colorectal cancer. In clinical practice, patients with these syndromes need to be identified to ensure that they and their families receive genetic counseling and testing and appropriate risk-reducing treatment. Genetic testing can offer a precise diagnosis. It allows for risk stratification and focused management and surveillance.
Related Concept Videos
Cancer Prevention
Some...
Serum Laboratory Studies, Stool Test, Breath Test
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
